Company Filing History:
Years Active: 2012
Title: Elizabeth Roddy: Innovator in Pharmaceutical Chemistry
Introduction
Elizabeth Roddy is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on crystalline forms of chemical compounds. Her dedication to research and development has led to advancements that can impact medical treatments.
Latest Patents
Elizabeth Roddy holds a patent for a novel crystalline form of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid. This invention relates to a unique crystalline form (Form A) of the compound, which is essential for pharmaceutical compositions. The patent outlines processes for forming this crystalline structure and its potential use in medical treatment.
Career Highlights
Roddy is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research. With a focus on innovative solutions, she continues to push the boundaries of pharmaceutical science.
Collaborations
Elizabeth has worked alongside notable colleagues such as Yugang Liu and Dimitris Papoutsakis. These collaborations have fostered an environment of creativity and innovation, leading to advancements in their respective fields.
Conclusion
Elizabeth Roddy's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medical science. Her patent and ongoing work at Novartis AG highlight her commitment to improving healthcare through research and development.